Elevated atherogenic index linked to higher erectile dysfunction risk

Study identifies a significant link between higher atherogenic index of plasma (AIP) levels and increased erectile dysfunction (ED) risk among US men, with implications for early intervention and cardiovascular health.

Ginkgo uncertain over the future of US government funding, stock drops

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 27, 2025

Gilgamesh Scoops $14m from NIDA to Develop Safer Ibogaine Analog for Opioid Use Disorder – Psychedelic Alpha

Psychedelic drug developer Gilgamesh Pharmaceuticals has scooped a grant worth $14m from the National Institute on Drug Abuse (NIDA) to develop its ibogaine analog, GM-3009,

March 14, 2024

Diabetic Eye Screening: Reducing Frequency May Raise Retinal Risks

Reducing the frequency of eye screening in patients with diabetes from annually to every other year would delay detection of sight-threatening diabetic retinopathy (STDR) and

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.